<--- Back to Details
First PageDocument Content
Pharmaceutics / Clinical research / Pharmaceutical industry / Bioequivalence / Abbreviated New Drug Application / Bioavailability / Dissolution testing / Cmax / Committee for Medicinal Products for Human Use / Pharmaceutical sciences / Pharmacology / Pharmacokinetics
Date: 2013-07-21 05:57:55
Pharmaceutics
Clinical research
Pharmaceutical industry
Bioequivalence
Abbreviated New Drug Application
Bioavailability
Dissolution testing
Cmax
Committee for Medicinal Products for Human Use
Pharmaceutical sciences
Pharmacology
Pharmacokinetics

Add to Reading List

Source URL: www.ema.europa.eu

Download Document from Source Website

File Size: 232,75 KB

Share Document on Facebook

Similar Documents

This feature can be accessed in its entirety at www.pharmtech.com/ptedigital0510 Analytical techniques Innovations in dissolution testing

DocID: 1uQwT - View Document

NEWS RELEASE New media prep station from Copley Scientific increases productivity in tablet dissolution testing 18 July 2013: Nottingham, UK: The new Dissomate media preparation unit from Copley Scientific is an automate

DocID: 1uyng - View Document

Pharmaceutical industry / Dissolution testing / Quality control / Packaging / Business / Beverage can

RRT 10 BioDis Multiple media pH-change dissolution testing for USP 3 and 7 Multiple media pH-change testing with a touch

DocID: 1q9vg - View Document

Chromatography / Analytical chemistry / Medical equipment / High-performance liquid chromatography / Pump / Syringe / Filtration / Peristaltic pump

Dissolution Offline System Semi-automated Dissolution System USP Apparatus 1, 2, 5 and 6 For testing of higher volumes, ERWEKA offers the system combination DT 161x, IPC 16 and FRL, where 12 or even 14 sam

DocID: 1pdFB - View Document

Pharmaceutical sciences / Atypical antipsychotics / Lactams / Piperidines / Bioequivalence / Clinical research / Risperidone / Cmax / Dissolution testing / Pharmacokinetics / Pharmacology / Chemistry

DIVISION OF BIOEQUIVALENCE REVIEW

DocID: 19Em6 - View Document